Developing CLL Treatment Classes

Recently, many approved and developing CLL therapies have aimed to inhibit rather than destroy cancer cells, often replacing the more toxic chemotherapy standard. BTK and PI3K inhibitor classes have b... Author: patientpower Added: 09/25/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts